OncologyTube Professional - Patients Click Here
160,418 video views
P2Professional: Videos
How can patients navigate between treatment options with all of the recent breakthroughs in myeloma therapy? Dr. Guilherme Perini, a Brazilian hematologist, joined Patient Power at the 2017 American Society of Hematology (ASH) meeting to inform myeloma patients what testing should be done and what t...
by:P2Professional | 989 views
Where is lymphoma treatment today? Stay in the know with Brazilian hematologist Dr. Guilherme Perini as he discusses advances in treatment from the 2017 American Society of Hematology meeting. He also shares the challenges lymphoma patients in Brazil face in gaining access to new lymphoma therapies. Watch now to learn the latest from this lymphoma ...
by:P2Professional | 901 views
The landscape of myeloma care is constantly evolving with the development of new research and treatment. While advances in myeloma therapies are exciting and beneficial, some patients feel overwhelmed making treatment decisions between all the available options. Myeloma patient Jack Aiello leads a d...
by:P2Professional | 824 views
What have researchers discovered about ROR1 and its role in targeted CLL therapies? Andrew Schorr hosts coverage from the 2017 American Society of Hematology (ASH) conference to learn about the latest innovations in CLL research and treatment. Tune in to hear Dr. Michael Choi, from the UCSD Moores Cancer Center, discuss ROR1 and its innovative role...
by:P2Professional | 1013 views
Can today’s medicines be used together to treat CLL more effectively? CLL expert Dr. Michael Choi of UC San Diego Moores Cancer Center joins Patient Power’s Andrew Schorr at the 2017 American Society of Hematology (ASH) conference. Dr. Choi provides an update on current medicines and discusses promising combination therapies for CLL, including rese...
by:P2Professional | 855 views
Where do things stand now with personalizing myeloma therapy to a patient’s genetic profile? At the American Society of Hematology (ASH) 2017 conference in Atlanta, Esther Schorr speaks with Dr. Gareth Morgan, Director of the UAMS Myeloma Institute, about new oncogenes in myeloma. They also discuss ...
by:P2Professional | 434 views
Chimeric antigen receptor (CAR) T-cell therapy has been receiving buzz as a promising treatment for cancer patients. So which CAR T-cell treatments are currently approved? Dr. David Maloney, Medical Director of the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance, joins Patient Power at the 2017 American Society of Hematology (ASH)...
by:P2Professional | 163 views
What’s the latest information about MPN treatment and research? As part of our ASH 2017 coverage, Dr. John Crispino and Dr. Angela Fleischman, Joined Patient Power to share what they learned at this year’s annual meeting in Atlanta. Both researchers in the condition of myeloproliferat​ive neoplasms (MPNs), they discussed treatment advances, particul...
by:P2Professional | 134 views
What does the future of treatment for mantle cell lymphoma look like? From the 2017 American Society of Hematology (ASH) annual meeting, Dr. Michael Wang discussed the modern approach to therapy and recently approved medicines. He also shared his research goals and his dedication to The University o...
by:P2Professional | 355 views
What’s the latest news on CAR-T cell therapy from the American Society Hematology (ASH) conference 2017 as we report on location from Atlanta? Expert Dr. Jon Arnason, from Beth Israel Deaconess Medical Center, shares new research released, which diseases the treatment can be used for, and when it’s appropriate to use. Tune in to hear how the clinic...
by:P2Professional | 216 views